Next Article in Journal
Fluorescent Dye-Doped Brightening Polymer-Stabilized Bistable Cholesteric Liquid Crystal Films
Next Article in Special Issue
Direct Homogeneous Synthesis of Compounds with Two O Atoms and Long-Chain Hydrocarbons from CO and H2: Co–Ru/N-methylpyrrolidone Catalyst
Previous Article in Journal
Photogrammetry of Ultrafast Excited-State Intramolecular Proton Transfer Pathways in the Fungal Pigment Draconin Red
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 8
10.3390/molecules28083508
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Efficient Synthesis of Oxygen-Bridged Spirooxindoles via Microwave-Promoted Multicomponent Reaction

by
Yaojing Shi
,
Hua Zhao
* and
Yufen Zhao
Institute of Drug Discovery Technology, Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo 315211, China
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(8), 3508; https://doi.org/10.3390/molecules28083508
Submission received: 17 March 2023 / Revised: 9 April 2023 / Accepted: 11 April 2023 / Published: 16 April 2023
(This article belongs to the Special Issue Green Organic Synthesis: Novel Approaches)
Browse Figures
Versions Notes

Abstract

:
A microwave-promoted multicomponent reaction of isatins, α-amino acids and 1,4-dihydro-1,4-epoxynaphthalene is achieved under environmentally friendly conditions, delivering oxygen-bridged spirooxindoles within 15 min in good to excellent yields. The attractive features of the 1,3-dipolar cycloaddition are the compatibility of various primary amino acids and the high efficiency of the short reaction time. Moreover, the scale-up reaction and synthetic transformations of spiropyrrolidine oxindole further demonstrate its synthetic utility. This work provides powerful means to expand the structural diversity of spirooxindole as a promising scaffold for novel drug discovery.

1. Introduction

Green chemistry is essential to contribute to sustainability, it minimizes the energy requirements, reagent consumption, as well as the generation of wastes [1,2,3]. Microwave technology is in line with the category of green chemistry, since the first reports in the 1980s, microwave technology has proven to be a valuable tool for synthetic organic chemistry [4,5,6,7,8]. Reactions can be completed in minutes usually, and both product yields and selectivity can often be enhanced over conventional approaches. Compared with traditional thermal conditions (oil bath or a heating block), the distinctive features of microwave-assisted reactions include superior reaction efficiency, environmentally benign reaction condition, better control of the reaction process, and its capability to rapidly screen a wide range of experimental parameters. Based on the above characteristics, microwave technology provides a more convenient and ingenious alternative for green synthesis of high-value chemicals.
Multicomponent reactions (MCRs) represent one of the most powerful reactions leading to structurally diverse molecules, which allow the creation of several chemical bonds from simple starting material in one pot [9,10,11,12,13]. The remarkable advantages of multicomponent reactions include high bond-forming efficiency, operational simplicity and superior atom economy, making them convenient over the stepwise methods. Among the various N-heterocycles, spirooxindoles are featured widely in a variety of pharmacologically active substances [14,15], which is of great interest to synthetic chemists. [16,17,18,19,20,21,22,23,24]. As one of the most attractive subtypes, spiropyrrolidine oxindoles often exhibit intriguing biological activities [25]. Multicomponent reactions provide key opportunities for the construction of spiropyrrolidine oxindoles, and significant efforts have been made toward the designing of novel and practical strategies to access this important class of compounds [26,27,28,29,30,31].
We notice that oxabicyclic alkenes show potentially interesting reactivities owing to the inherent strain, and they have been widely employed in both ring-retentive and ring-opening catalytic transformations, including dimerization [32], cycloaddition [33,34,35], ring-opening/rearrangement reaction [36], hydrofunctionalization [37,38,39,40], and C−H activation [41,42]. Though great success has been achieved in traditional 1,3-dipolar cycloaddition of azomethine ylides prepared from isatins and α-amino acids with various electron-deficient alkenes as dienophiles, the strained oxabicyclic alkenes are scarcely involved. To the best of our knowledge, there is only an elegant work disclosed by Parthasarathy and co-workers (Scheme 1a). They explored 1,3-dipolar cycloaddition of azomethine ylides with heterobicyclic alkenes at 80 °C for 6 h [43]. Despite considerable progress, it cannot be ignored that it remains a few challenges in the current method. One is the limited amino acids substrate scope, as the reported work focuses on sarcosine and proline. Moreover, the required reaction time often lasts for hours. Therefore, the synthesis of oxygen-bridged spirooxindoles in several minutes with diverse primary amino acids as substrates is quite challenging and not established. With these problems in mind, and in continuation of our interest in the 1,3-dipolar cycloaddition (Scheme 1b) [44], we wish to offer a microwave-promoted multicomponent reaction for the synthesis of oxygen-bridged spirooxindoles in a very short time with diverse primary amino acids as reaction partners (Scheme 1c).

2. Results and Discussion

We commenced our investigation with isatin 1a, proline 2a and 1,4-dihydro-1,4-epoxynaphthalene 3a as model substrates. To our delight, microwave irradiation can promote the desired annulation reaction under catalyst- or additive-free conditions. Treatment of 1a, 2a and 3a in THF at 70 °C for 15 min, the desired corresponding [3+2] annulation product 4a was obtained as a single diastereomer in 40% yield (Table 1, entry 1). Encouraged by the initial result, we then focused on solvent screening; typical polar and nonpolar solvents were tested for the reaction. Generally, the results revealed that the solvents have a great influence on the reaction outcome, and alcohols are better than other solvents (Table 1, entries 2–8). Notably, MeOH gave the optimal results (73% yield, Table 1, entry 5). Further extensive studies regarding the temperature were conducted; however, improving or lowering the temperature was not beneficial to the reaction outcome (entries 9–11). A further increase in the reaction time (20, 25 or 30 min) did not significantly improve the reaction yield (entries 12–14), and a shorter time (10 min) indicated a negative effect on the result of the reaction (entry 15). Finally, the yield could be improved to 83% by switching the equivalent of reactants (entries 16–17).
With the optimal conditions in hand, we explored the substrates’ scope of isatins, and the results were summarized in Scheme 2. Generally, isatins with various substitutions were suitable to the reaction condition. When 4-bromoisatin was subjected to the 1,3-dipole cycloaddition, product 4b was obtained in 33% yield. We speculated that the lower reaction activity was attributed to a large steric hindrance group nearby the reactive center. Isatins equipped with electron-donating (methyl) or electron-withdrawing group (fluoro, chloride, bromide, nitro) at the C5 position of the benzene ring were well-tolerated for the cycloaddition, affording the desired adducts in good to excellent yields (4c–4g, 72–89% yields). Meanwhile, 6-methoxy-isatin participated in the three-component reaction smoothly, and 4h was separated in 88% yield. When the substitution of bromide was far away from the active center, there was no obvious influence on the reaction result (87% yield of 4i). Next, isatins with the N-protection group were explored, and the outcome showed that alkyl and phenyl groups were friendly to this reaction, giving 4j and 4k in 94% and 91% yields, respectively. However, N-acetyl protected isatin furnished only trace products. Furthermore, other diketones and their analogs such as acenaphthequinone and ninhydrin were also found to be effective, as demonstrated in the successful installation of 4m and 4n. However, other diketones including 9,10-phenanthrenequinone, 1,2-diphenyl ethanedione, cyclohexanedione, acetylacetone, ethyl pyruvate and ethyl 3,3,3- trifluoropyruvate failed to undergo this reaction under standard conditions.
Next, to examine the feasibility of this reaction, we examined the variation of the amino acid component toward the formation of oxygen-bridged spirooxindoles (Scheme 3). Initially, the natural L-alanine was found to be unfruitful for the optimal condition, and no desired product could be isolated from the reaction mixture. We speculated that the side reactions of azomethine ylides from isatin and L-alanine are largely preferred over [3+2] cycloadditions with a dipolarophile, which makes this reaction particularly challenging. Gratefully, we found that the L-phenylalanine proceeded smoothly in methanol−water medium (MeOH:H2O = 3:1), but changing the solvent still had no positive effect on alanine. Under similar conditions, the present cycloaddition reaction was also successfully extended to other primary α-amino acids with side chains, thus greatly expanding the types of spirooxindoles accessible using this method. 4-Iodo-L-phenylalanine and L-tyrosine led to the 5b and 5c in 57% and 21% yields, respectively. It is worth noting that N-methyl protection is necessary for 5c, otherwise, no expected product was observed in the reaction system. As a common intermediate in about 20 new antihypertensive drugs in the world, L-homophenylalanine showed quite promising reactivities, leading to the desired product 5d in moderate yield. The three-component reaction of isatin with L-methionine, L-lysine and L-leucine with 3a resulted in the expected products in 73–80% yields as single isomers. It was found that the L-isoleucine afforded the spirooxindoles 5h as chromatographically separable diastereomers (1.7:1 dr). The use of tryptophan as a reaction partner proved to have low efficiency, delivering the corresponding product 5i in only trace yield. It was hypothesized that in the presence of unprotected amino acid residues, the side reactions were preferred over the expected cyclization reaction. Next, L-thiproline was tested, and 5j was obtained with a 78% yield. The structure and relative stereochemistry of 5j was unambiguously established by Single-crystal X-ray analysis (CCDC: 2243483). When trans-4-cyclohexyl-L-proline was selected for the cycloaddition, the two diastereomers of 5k were isolated in almost the same yield (46% vs. 42%). In contrast, the utilization of L-piperidine-2-carboxylic acid, L-serine and peptide L-Ala-L-Ala-OH proved unsuccessful for the reaction conditions.
Based on the experimental results and the reported literature [45], possible mechanisms for cycloaddition were proposed as shown in Scheme 4. First, the condensation of isatin 1a with proline 2a, followed by decarboxylation furnishes ylide intermediate A, which reacts as a 1,3-dipole with 3a through two possible pathways A and B. Path A leads to the formation of the thermodynamically more stable endo-cycloadduct 4a, whereas affording the exo-cycloadduct 4a’ through path B is probably disfavored.
To explore the synthetic utility of this established protocol, we investigated the one-pot three-component [3+2] cycloaddition cascade on a gram scale, affording the corresponding 6 in synthetically useful yield (61%) with excellent diastereoselectivity (Sheme 5). To further illustrate the synthetic values of this three-component reaction, the derivatizations of the gram reaction product were carried out (Scheme 5). First, in the presence of TfOH, compound 6 was successfully transformed into product 7 by deoxyaromatization. Then, 6 was treated with (Boc)2O/DMAP, affording N-Boc substituted spirooxindole 8 in good yield. Next, by reduction of 6 with LiAlH4 in diethyl ether at ambient temperature, 2-hydroxyindoline 9 was obtained as a single diastereomer in 64% yield. These representative examples highlight the advantages and potential application of this method.

3. Materials and Methods

3.1. General Information

All starting materials were purchased from commercial suppliers and used without further purification unless otherwise stated. Thin-layer chromatography (TLC) was conducted with 0.25 mm Tsingdao silica gel plates (60F-254) and visualized by exposure to UV light (254 nm). Flash column chromatography was performed on Tsingdao silica gel (200–300 mesh) and neutral/basic aluminum oxide (200–300 mesh). 1H NMR spectra were recorded with Bruker spectrometers (400 or 500 MHz) and reported relative to deuterated solvent signals or tetramethylsilane internal standard signals (see Supplementary Materials). Data for 1H NMR spectra were reported as follows: chemical shift (δ/ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constant (J/Hz) and integration. 13C NMR spectra were recorded with Bruker spectrometers (125 MHz). Data for 13C NMR spectra were reported in terms of chemical shift. 19F NMR spectra were recorded with Bruker spectrometers (470 MHz). High-resolution mass spectrometry (HRMS) was conducted with a Bruker Apex IV RTMS. All microwave reactions were conducted in sealed glass vials with a microwave reactor, Discover SP from CEM Corp.

3.2. General Procedure for the Microwave Assisted 1,3-dipolar Cycloaddition of Azomethine Ylides Prepared from Isatins and α-Amino Acids with 1,4-dihydro-1,4-epoxynaphthalene

A glass vial was charged with Isatins 1 (0.20 mmol, 1.0 equiv), α-Amino Acids 2 (0.2 mmol, 1.0 equiv), 1,4-dihydro-1,4-epoxynaphthalene 3 (0.3 mmol, 1.5 equiv) and 2 mL of solvent (MeOH or MeOH/H2O = 3:1). The resulting mixture was placed in a monowave 200 microwave synthesis reactor and stirred at 70 °C for 15 min under air. After completion of the reaction as monitored by TLC, the resulting crude product was concentrated under reduced pressure, and the resulting crude product was purified by column chromatography to provide the desired product.

3.2.1. 1′,2′,3′,5a’,6′,11′,11a’,11b’-Octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4a)

Eluent = petroleum ether/EtOAc (1:1). white solid (57 mg, 83%). mp: 172−175 °C. 1H NMR (500 MHz, CDCl3) δ 8.52 (s, 1H), 7.54 (d, J = 7.5 Hz, 1H), 7.29 (td, J = 7.5, 1.0 Hz, 1H), 7.24 (d, J = 7.0 Hz, 1H), 7.16–6.99 (m, 4H), 6.91 (d, J = 8.0 Hz, 1H), 5.43 (s, 1H), 5.12 (s, 1H), 4.23–4.19 (m, 1H), 2.89 (d, J = 8.0 Hz, 1H), 2.82 (dt, J = 9.0, 7.0 Hz, 1H), 2.75 (t, J = 8.0 Hz, 1H), 2.48 (td, J = 9.0, 3.5 Hz, 1H), 2.01–1.90 (m, 3H), 1.88–1.81 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 182.3, 146.9, 145.3, 141.9, 129.2, 128.4, 127.2, 126.9, 126.6, 122.3, 119.6, 119.0, 110.2, 80.3, 80.1, 71.3, 65.6, 58.4, 48.7, 46.2, 26.8, 25.5. HRMS (ESI-TOF): m/z calcd. for C22H21N2O2: 345.1603 [M+H]+; found: 345.1600.

3.2.2. 4-Bromo-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4b)

Eluent = petroleum ether/EtOAc (5:1). white solid (28 mg, 33%). mp: 248–250 °C. 1H NMR (400 MHz, DMSO-d6) δ 7.40 (d, J = 7.2 Hz, 1H), 7.31–7.24 (m, 3H), 7.22–7.13 (m, 2H), 6.90 (d, J = 7.2 Hz, 1H), 5.45 (s, 1H), 5.32 (s, 1H), 3.79–3.69 (m, 1H), 2.73 (t, J = 8.8 Hz, 1H), 2.64–2.61 (m, 1H), 2.48 (d, J = 7.2 Hz, 1H), 2.40–2.34 (m, 1H), 2.09–1.96 (m, 3H), 1.85–1.77 (m, 1H). 13C NMR (125 MHz, DMSO-d6) δ 181.9, 147.1, 145.3, 144.7, 131.1, 128.0, 127.6, 127.0, 126.9, 120.7, 120.4, 119.2, 109.7, 83.4, 80.1, 78.1, 71.9, 61.7, 49.9, 49.1, 32.6, 28.4. HRMS (ESI-TOF): m/z calcd. for C22H20BrN2O2: 423.0708 [M+H]+; found: 423.0706.

3.2.3. 5-Methyl-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4c)

Eluent = petroleum ether/EtOAc (1:1). white solid (59 mg, 82%). mp: 183−185 °C. 1H NMR (500 MHz, CDCl3) δ 8.21 (s, 1H), 7.38 (s, 1H), 7.27 (d, J = 7.5 Hz, 1H), 7.20–7.07 (m, 4H), 6.82 (d, J = 8.0 Hz, 1H), 5.47 (s, 1H), 5.22 (s, 1H), 4.26–4.22 (m, 1H), 2.89 (d, J = 7.5 Hz, 1H), 2.86 (t, J = 8.0 Hz, 1H), 2.74 (t, J = 8.0 Hz, 1H), 2.49 (td, J = 9.0, 4.0 Hz, 1H), 2.39 (s, 3H), 2.04–1.87 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 181.6, 146.9, 145.3, 139.4, 131.8, 129.5, 128.9, 127.1, 126.9, 126.6, 119.6, 119.0, 109.8, 80.4, 80.0, 70.8, 65.4, 58.3, 48.4, 45.8, 26.8, 25.2, 21.3. HRMS (ESI-TOF): m/z calcd. for C23H23N2O2: 359.1760 [M+H]+; found: 359.1753.

3.2.4. 5-Fluoro-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4d)

Eluent = MeOH/DCM (1:80). white solid (55 mg, 76%). mp: 156–158 °C. 1H NMR (500 MHz, CDCl3) δ 8.30 (s, 1H), 7.33 (dd, J = 8.5, 3.0 Hz, 1H), 7.25 (d, J = 7.5 Hz, 1H), 7.14 (td, J = 7.0, 2.0 Hz, 1H), 7.12–7.06 (m, 2H), 7.01 (td, J = 8.5, 2.5 Hz, 1H), 6.84 (dd, J = 8.5, 4.5 Hz, 1H), 5.42 (s, 1H), 5.08 (s, 1H), 4.19–4.15 (m, 1H), 2.92 (d, J = 8.0 Hz, 1H), 2.76–2.72 (m, 2H), 2.50 (td, J = 9.0, 4.0 Hz, 1H), 2.06–1.82 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 182.1, 158.9 (J = 240.0 Hz), 146.9, 145.0, 137.7, 128.9, 127.0, 126.6, 119.7, 119.0, 116.2 (J = 25.0 Hz), 115.7 (J = 23.7 Hz), 110.5 (J = 8.7 Hz), 80.2, 80.1, 71.6, 65.9, 58.5, 48.5, 45.7, 26.8, 25.4. 19F NMR (471 MHz, CDCl3) δ -120.3. HRMS (ESI-TOF): m/z calcd. for C22H20FN2O2: 363.1509 [M+H]+; found: 363.1501.

3.2.5. 5-Chloro-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4e)

Eluent = petroleum ether/EtOAc (1:1). white solid (61 mg, 81%). mp: 211–213 °C. 1H NMR (500 MHz, DMSO-d6) δ 10.42 (s, 1H), 7.36 (d, J = 9.0 Hz, 1H), 7.34 (s, 1H), 7.31 (d, J = 7.0 Hz, 1H), 7.23 (d, J = 7.0 Hz, 1H), 7.14 (t, J = 7.5 Hz, 1H), 7.09 (t, J = 7.5 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 5.53 (s, 1H), 5.11 (s, 1H), 4.06–3.83 (m, 1H), 2.67 (d, J = 7.5 Hz, 1H), 2.65–2.56 (m, 1H), 2.47 (t, J = 8.0 Hz, 1H), 2.28–2.16 (m, 1H), 2.01–1.66 (m, 4H). 13C NMR (125 MHz, DMSO-d6) δ 180.4, 147.7, 145.7, 142.6, 129.5, 127.8, 127.1, 126.7, 125.8, 120.4, 119.4, 111.7, 80.1, 79.6, 70.4, 65.3, 58.0, 48.8, 45.6, 26.8, 25.1. HRMS (ESI-TOF): m/z calcd. for C22H20ClN2O2: 379.1213 [M+H]+; found: 379.1206.

3.2.6. 5-Bromo-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4f)

Eluent = petroleum ether/EtOAc (1:1). white solid (71 mg, 84%). mp: 256−258 °C. 1H NMR (500 MHz, CDCl3) δ 7.77 (s, 1H), 7.68 (d, J = 2.0 Hz, 1H), 7.44 (dd, J = 8.5, 2.0 Hz, 1H), 7.24 (d, J = 8.0 Hz, 1H), 7.20–7.05 (m, 3H), 6.80 (d, J = 8.0 Hz, 1H), 5.44 (s, 1H), 5.13 (s, 1H), 4.20–4.15 (m, 1H), 2.89 (d, J = 7.5 Hz, 1H), 2.80–2.76 (q, J = 7.5 Hz, 1H), 2.71 (t, J = 8.0 Hz, 1H), 2.49–2.41 (m, 1H), 2.06–2.00 (m, 1H), 1.95–1.85 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 181.1, 146.9, 144.9, 140.7, 132.2, 131.2, 129.4, 127.0, 126.7, 119.7, 119.0, 115.3, 111.4, 80.2, 80.0, 70.9, 65.6, 58.5, 48.4, 45.6, 26.9, 25.2. HRMS (ESI-TOF): m/z calcd. for C22H20BrN2O2: 423.0708 [M+H]+; found: 423.0702.

3.2.7. 5-Nitro-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4g)

Eluent = petroleum ether/EtOAc (2:1). white solid (69 mg, 89%). mp: 176−178 °C. 1H NMR (500 MHz, DMSO-d6) δ 11.00 (s, 1H), 8.28 (dd, J = 8.5, 2.0 Hz, 1H), 8.20 (d, J = 2.5 Hz, 1H), 7.32 (d, J = 7.0 Hz, 1H), 7.19 (d, J = 7.0 Hz, 1H), 7.15 (t, J = 7.0 Hz, 1H), 7.11–7.08 (m, 1H), 7.07 (d, J = 8.5 Hz, 1H), 5.57 (s, 1H), 5.17 (s, 1H), 4.00–3.96 (m, 1H), 2.75 (d, J = 7.5 Hz, 1H), 2.69–2.56 (m, 1H), 2.49 (d, J = 7.5 Hz, 1H), 2.25 (td, J = 8.5, 3.5 Hz, 1H), 1.97–1.79 (m, 3H), 1.79–1.69 (m, 1H). 13C NMR (125 MHz, DMSO-d6) δ 181.1, 150.2, 147.8, 145.6, 142.5, 128.4, 127.1, 126.9, 126.7, 123.4, 120.4, 119.4, 110.4, 80.1, 79.6, 69.9, 65.4, 58.2, 48.8, 45.5, 26.8, 25.1. HRMS (ESI-TOF): m/z calcd. for C22H20N3O4: 390.1454 [M+H]+; found:390.1449.

3.2.8. 6-Methoxy-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4h)

Eluent = petroleum ether/EtOAc (2:1). white solid (66mg, 88%). mp: 196−198 °C. 1H NMR (400 MHz, CDCl3) δ 8.82 (s, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.28 (d, J = 7.2 Hz, 1H), 7.19–7.07 (m, 3H), 6.63 (dd, J = 8.4, 2.4 Hz, 1H), 6.55 (d, J = 2.4 Hz, 1H), 5.45 (s, 1H), 5.12 (s, 1H), 4.22–4.19 (m, 1H), 3.85 (s, 3H), 2.91 (d, J = 8.0 Hz, 1H), 2.86 (t, J = 8.0 Hz, 1H), 2.80 (t, J = 8.0 Hz, 1H), 2.55 (td, J = 8.8, 3.2 Hz, 1H), 2.08–1.95 (m, 3H), 1.90–1.83 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 182.7, 160.8, 146.8, 145.3, 143.3, 129.2, 126.9, 126.6, 119.6, 119.0, 118.5, 107.1, 97.4, 80.3, 80.1, 71.4, 65.6, 58.1, 55.5, 48.9, 46.6, 26.7, 25.7. HRMS (ESI-TOF): m/z calcd. for C23H23N2O3: 375.1709 [M+H]+; found: 375.1700.

3.2.9. 7-Bromo-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4i)

Eluent = petroleum ether/EtOAc (5:1). white solid (73 mg, 87%). mp: 220−223 °C. 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 7.5 Hz, 1H), 7.44 (dd, J = 8.0, 1.0 Hz, 1H), 7.40 (s, 1H), 7.24 (d, J = 9.5 Hz,1H), 7.14 (td, J = 7.0, 2.0 Hz, 1H), 7.12–7.06 (m, 2H), 7.01 (t, J = 7.5 Hz, 1H), 5.43 (s, 1H), 5.11 (s, 1H), 4.17–4.15 (m, 1H), 2.90 (d, J = 7.5 Hz, 1H), 2.79–2.72 (m, 1H), 2.71 (t, J = 8.0 Hz, 1H), 2.45 (td, J = 8.5, 4.5 Hz, 1H), 2.04–1.96 (m, 1H), 1.96–1.82 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 180.1, 146.9, 145.0, 140.8, 131.8, 128.8, 127.2, 127.0, 126.7, 123.6, 119.7, 119.0, 103.3, 80.3, 80.0, 72.0, 65.6, 58.7, 48.3, 45.5, 26.9, 25.2. HRMS (ESI-TOF): m/z calcd. for C22H20BrN2O2: 423.0708 [M+H]+; found: 423.0702.

3.2.10. 1-Methyl-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4j)

Eluent = petroleum ether/EtOAc (1:1). white solid (67 mg, 94%). mp: 195−197 °C. 1H NMR (400 MHz, CDCl3) δ 7.58 (dd, J = 7.6, 1.2 Hz, 1H), 7.38 (td, J = 7.6, 1.2 Hz, 1H), 7.24 (d, J = 6.8 Hz, 1H), 7.15–7.09 (m, 2H), 7.07–7.04 (m, 2H), 6.88 (d, J = 8.0 Hz, 1H), 5.45 (s, 1H), 5.18 (s, 1H), 4.29–4.23 (m, 1H), 3.17 (s, 3H), 2.88 (dt, J = 8.4, 7.2 Hz, 1H), 2.81 (d, J = 7.6 Hz, 1H), 2.73 (t, J = 8.0 Hz, 1H), 2.41 (td, J = 8.8, 3.2 Hz, 1H), 2.02–1.92 (m, 3H), 1.89–1.79 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 179.6, 147.0, 145.4, 144.9, 129.2, 128.0, 126.8, 126.7, 126.5, 122.3, 119.5, 119.0, 108.2, 80.4, 80.1, 70.4, 65.1, 58.3, 49.1, 46.3, 26.9, 26.1, 25.3. HRMS (ESI-TOF): m/z calcd. for C23H23N2O2: 359.1760 [M+H]+; found: 359.1755.

3.2.11. 1-Phenyl-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4k)

Eluent = petroleum ether/EtOAc (3:1). white solid (76 mg, 91%). mp: 205−207 °C. 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 7.6 Hz, 1H), 7.50 (t, J = 7.6 Hz, 2H), 7.41 (d, J = 7.6 Hz, 2H), 7.37 (d, J = 7.6 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 7.25 (d, J = 7.6 Hz, 1H), 7.21–7.06 (m, 4H), 6.88 (d, J = 8.0 Hz, 1H), 5.49 (s, 1H), 5.33 (s, 1H), 4.29–4,23 (m, 1H), 2.97–2.91 (m, 1H), 2.93 (d, J = 7.6 Hz, 1H), 2.71 (t, J = 7.6 Hz, 1H), 2.47 (td, J = 8.0, 4.0 Hz, 1H), 2.13–1.89 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 178.7, 147.1, 145.4, 144.7, 134.4, 129.5, 129.1, 128.3, 127.9, 126.9, 126.7, 126.6, 122.8, 119.6, 119.0, 109.5, 80.5, 80.1, 69.8, 65.0, 58.7, 48.5, 45.5, 26.9, 25.0. HRMS (ESI-TOF): m/z calcd. for C28H25N2O2:421.1916 [M+H]+; found: 421.1909.

3.2.12. 1′,2′,3′,5a’,6′,11′,11a’,11b’-Octahydro-2H-spiro[acenaphthylene-1,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (4m)

Eluent = petroleum ether/EtOAc (4:1). yellow solid (50 mg, 66%). mp: 228−230 °C. 1H NMR (500 MHz, CDCl3) δ 8.17 (d, J = 8.0 Hz, 1H), 7.98 (d, J = 2.5 Hz, 1H), 7.96 (d, J = 4.0 Hz, 1H), 7.88 (d, J = 7.0 Hz, 1H), 7.78 (d, J = 7.0 Hz, 1H), 7.75 (d, J = 7.0 Hz, 1H), 7.29 (d, J = 6.0 Hz, 1H), 7.15 (t, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 7.03 (d, J = 7.5 Hz, 1H), 5.52 (s, 1H), 5.26 (s, 1H), 4.34–4.29 (m, 1H), 2.97–2.89 (m, 2H), 2.86 (t, J = 8.0 Hz, 1H), 2.40 (td, J = 8.5, 3.5 Hz, 1H), 2.18–1.95 (m, 3H), 1.91–1.79 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 206.9, 146.9, 145.6, 142.9, 136.9, 131.6, 131.3, 130.9, 128.4, 128.2, 126.8, 126.6, 125.1, 124.8, 122.1, 119.5, 119.0, 80.8, 80.3, 74.8, 65.6, 57.9, 50.1, 47.2, 26.9, 25.7. HRMS (ESI-TOF): m/z calcd. for C26H22NO2: 380.1651 [M+H]+; found: 380.1643.

3.2.13. 1′,2′,3′,5a’,6′,11′,11a’,11b’-Octahydrospiro[indene-2,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindole]-1,3-dione (4n)

Eluent = petroleum ether/EtOAc (3:1). yellow solid (52 mg, 73%). mp: 144−146 °C. 1H NMR (500 MHz, DMSO-d6) δ 8.06–8.02 (m, 1H), 7.99 (td, J = 5.4, 2.7 Hz, 2H), 7.96 (dq, J = 5.8, 2.1, 1.5 Hz, 1H), 7.30 (d, J = 7.0 Hz, 1H), 7.20–7.15 (m, 1H), 7.15–7.04 (m, 2H), 5.72 (s, 1H), 5.46 (s, 1H), 3.90 (td, J = 8.1, 6.4 Hz, 1H), 3.12 (ddd, J = 9.8, 8.2, 6.4 Hz, 1H), 2.64 (d, J = 7.5 Hz, 1H), 2.56 (t, J = 7.9 Hz, 1H), 2.25 (td, J = 7.8, 2.2 Hz, 1H), 2.04 (dtd, J = 12.5, 8.6, 6.3 Hz, 1H), 1.88 (dtt, J = 11.1, 5.7, 2.9 Hz, 2H), 1.67–1.54 (m, 1H). 13C NMR (125 MHz, DMSO-d6) δ 198.4, 147.4, 146.9, 142.7, 140.5, 137.0, 136.4, 126.8, 126.8, 124.4, 123.6, 119.9, 119.8, 79.4, 78.4, 70.6, 65.4, 55.8, 51.7, 47.7, 27.0, 25.4. HRMS (ESI-TOF): m/z calcd. for C23H20NO3: 358.1443 [M+H]+; found: 358.1440.

3.2.14. 3′-Benzyl-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-oneEluent (5a)

Petroleum ether/EtOAc (1:1). white solid (54 mg, 68%). mp: 135−137 °C. 1H NMR (500 MHz, CDCl3) δ 7.78 (s, 1H), 7.57 (d, J = 7.5 Hz, 1H), 7.40 (d, J = 7.5 Hz, 2H), 7.37–7.29 (m, 3H), 7.24 (t, J = 7.5 Hz, 1H), 7.18–7.09 (m, 5H), 6.88 (d, J = 8.0 Hz, 1H), 5.72 (s, 1H), 5.41 (s, 1H), 4.55–4.50 (m, 1H), 3.20 (dd, J = 12.0, 6.0 Hz, 1H), 3.16 (dd, J = 12.0, 7.0 Hz, 1H), 2.69 (t, J = 7.0 Hz, 1H), 2.62 (d, J = 6.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 181.5, 146.8, 145.1, 141.3, 139.3, 129.3, 128.9, 128.8, 128.6, 126.9, 126.6, 126.4, 126.3, 122.8, 119.5, 118.9, 109.9, 81.6, 80.4, 69.4, 59.1, 53.9, 51.7, 37.8. HRMS (ESI-TOF): m/z calcd. for C26H23N2O2: 395.1760 [M+H]+; found: 395.1752.

3.2.15. 3′-(4-Iodobenzyl)-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5b)

Eluent = petroleum ether/EtOAc (2:1). white solid (59 mg, 57%). mp: 159−161 °C. 1H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.5 Hz, 2H), 7.56 (d, J = 7.5 Hz, 1H), 7.52 (s, 1H), 7.34–7.29 (m, 1H), 7.22–7.17 (m, 1H), 7.17–7.08 (m, 5H), 6.88 (d, J = 7.5 Hz, 1H), 5.67 (s, 1H), 5.42 (s, 1H), 4.49–4.45 (m, 1H), 3.14 (dd, J = 14.0, 6.0 Hz, 1H), 3.14 (dd, J = 13.5, 8.5 Hz, 1H), 2.70 (t, J = 7.0 Hz, 1H), 2.62 (d, J = 7.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 181.4, 146.7, 145.1, 141.3, 139.0, 137.6, 130.9, 129.4, 127.0, 126.7, 126.3, 122.8, 119.5, 118.9, 110.0, 108.0, 91.5, 81.6, 80.4, 69.4, 58.9, 53.9, 51.7, 37.4. HRMS (ESI-TOF): m/z calcd. for C26H22IN2O2: 521.0726 [M+H]+; found: 521.0723.

3.2.16. 3′-(4-Hydroxybenzyl)-1-methyl-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5c)

Eluent = petroleum ether/EtOAc (1:1). yellow solid (18 mg, 21%). mp: 258−260 °C. 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 7.4 Hz, 1H), 7.38 (t, J = 7.7 Hz, 1H), 7.17 (dt, J = 7.7, 4.0 Hz, 2H), 7.14–7.03 (m, 5H), 6.86 (d, J = 7.8 Hz, 1H), 6.61 (d, J = 8.1 Hz, 2H), 5.70 (s, 1H), 5.43 (s, 1H), 4.49 (q, J = 7.3 Hz, 1H), 3.12 (s, 3H), 3.11–3.06 (m, 1H), 2.98 (dd, J = 14.0, 8.5 Hz, 1H), 2.70 (t, J = 7.0 Hz, 1H), 2.59 (d, J = 6.9 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 179.3, 154.8, 146.7, 145.0, 144.3, 130.3, 129.6, 128.0, 127.0, 126.7, 125.8, 123.1, 119.4, 118.9, 115.6, 108.6, 81.7, 80.5, 69.4, 59.9, 53.9, 52.1, 36.8, 26.1. HRMS (ESI-TOF): m/z calcd. for C27H25N2O3: 425.1865 [M+H]+; found: 425.1860.

3.2.17. 3′-Phenethyl-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5d)

Eluent = petroleum ether/EtOAc (1:1). white solid (41 mg, 50%). mp: 212−214 °C. 1H NMR (400 MHz, CDCl3) δ 7.84 (s, 1H), 7.50 (d, J = 7.6 Hz, 1H), 7.35–7.27 (m, 5H), 7.25–7.21 (m, 1H), 7.20–7.06 (m, 5H), 6.91 (d, J = 7.6 Hz, 1H), 5.54 (s, 1H), 5.41 (s, 1H), 4.18–4.11 (m, 1H), 2.94 (ddd, J = 14.0, 10.0, 6.0 Hz, 1H), 2.81 (ddd, J = 14.0, 10.0, 6.4 Hz, 1H), 2.68 (t, J = 7.2 Hz, 1H), 2.63 (d, J = 7.2 Hz, 1H), 2.22–2.11 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 181.0, 146.8, 145.1, 142.1, 141.4, 129.4, 128.5, 128.4, 127.0, 126.7, 126.1, 122.8, 119.5, 118.9, 110.1, 81.7, 80.4, 69.6, 58.9, 54.0, 52.5, 34.4, 33.6. HRMS (ESI-TOF): m/z calcd. for C27H25N2O2: 409.1916 [M+H]+; found: 409.1912.

3.2.18. 3′-(2-(Methylthio)ethyl)-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5e)

Eluent = MeOH/DCM (50:1). white solid (57 mg, 75%). mp: 203−205 °C. 1H NMR (500 MHz, CDCl3) δ 7.58 (s, 1H), 7.48 (d, J = 7.5 Hz, 1H), 7.31 (t, J = 8.0 Hz, 1H), 7.25 (s, 1H), 7.17–7.08 (m, 4H), 6.90 (d, J = 8.0 Hz, 1H), 5.57 (s, 1H), 5.40 (s, 1H), 4.16–4.10 (m, 1H), 3.74–3.70 (m, 1H), 2.76 (td, J = 13.0, 5.5 Hz, 1H), 2.72–2.66 (m, 2H), 2.62 (d, J = 7.0 Hz, 1H), 2.18 (s, 3H), 2.18–2.13 (m, 1H), 2.12–2.06 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 180.8, 146.7, 145.1, 141.3, 129.4, 128.6, 127.0, 126.7, 126.0, 122.8, 119.5, 118.9, 110.0, 81.7, 80.4, 69.6, 58.3, 54.0, 52.5, 32.5, 31.7, 15.9. HRMS (ESI-TOF): m/z calcd. for C22H23N2O2S: 379.1480 [M+H]+; found: 379.1474.

3.2.19. 3′-Isopropyl-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5f)

Eluent = petroleum ether/EtOAc (2:1). White solid (56 mg, 80%). Mp: 259−261 °C. 1H NMR (500 MHz, CDCl3) δ 7.84 (s, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.32 (td, J = 8.0, 1.5 Hz, 1H), 7.28 (d, J = 7.0 Hz, 1H), 7.19–7.10 (m, 4H), 6.91 (d, J = 8.0 Hz, 1H), 5.60 (s, 1H), 5.39 (s, 1H), 3.72–3.70 (m, 1H), 2.69 (t, J = 6.5 Hz, 1H), 2.63 (d, J = 7.0 Hz, 1H), 2.04–1.98 (m, 2H), 1.20 (d, J = 6.5 Hz, 3H), 1.14 (d, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 181.4, 147.3, 145.1, 141.3, 129.3, 128.9, 127.0, 126.6, 126.3, 122.8, 119.6, 118.6, 109.9, 81.8, 80.4, 69.6, 65.5, 53.7, 51.8, 30.1, 21.4, 20.9. HRMS (ESI-TOF): m/z calcd. For C22H23N2O2: 347.1760 [M+H]+; found: 347.1753.

3.2.20. 3′-Isobutyl-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5g)

Eluent = petroleum ether/EtOAc (2:1). white solid (53mg, 73%). mp: 250−252 °C. 1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 7.6 Hz, 1H), 7.31 (dd, J = 8.0, 6.8 Hz, 1H), 7.24 (d, J = 8.0, Hz,1H), 7.16–7.07 (m, 4H), 6.89 (d, J = 7.6 Hz, 1H), 5.57 (s, 1H), 5.40 (s, 1H), 4.15–4.10 (m, 1H), 2.66–2.60 (m, 2H), 1.87–1.81 (m, 1H), 1.72–1.67 (m, 2H), 1.03 (d, J = 6.4 Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 181.0, 147.0, 145.2, 141.4, 129.3, 128.7, 127.0, 126.6, 126.0, 122.7, 119.5, 118.8, 110.0, 81.7, 80.4, 69.7, 56.6, 54.0, 52.7, 40.5, 26.4, 23.3, 22.8. HRMS (ESI-TOF): m/z calcd. for C23H25N2O2: 361.1916 [M+H]+; found: 361.1907.

3.2.21. 3′-(sec-Butyl)-2′,3′,3a’,4′,9′,9a’-hexahydrospiro[indoline-3,1′-[4,9]epoxybenzo[f]isoindol]-2-one (5h)

For major isomer: Eluent = petroleum ether/EtOAc (2:1). green solid (42 mg, 59%). mp: 141−143 °C. 1H NMR (400 MHz, CDCl3) δ 7.78 (s, 1H), 7.51 (d, J = 7.6 Hz, 1H), 7.34–7.26 (m, 2H), 7.19–7.07 (m, 4H), 6.88 (d, J = 7.6 Hz, 1H), 5.53 (s, 1H), 5.37 (s, 1H), 3.81–3.77 (m, 1H), 2.68 (t, J = 6.8 Hz, 1H), 2.61 (d, J = 6.8 Hz, 1H), 1.80–1.71 (m, 2H), 1.41–1.30 (m, 1H), 1.10–1.04 (m, 6H). 13C NMR (125 MHz, CDCl3) δ 181.5, 147.3, 145.1, 141.4, 129.3, 128.9, 127.0, 126.6, 126.2, 122.7, 119.6, 118.6, 110.0, 81.9, 80.4, 69.6, 63.5, 53.4, 51.9, 36.0, 27.2, 16.8, 10.5. HRMS (ESI-TOF): m/z calcd. for C23H25N2O2: 361.1916 [M+H]+; found: 361.1910.
For minor isomer: Eluent = petroleum ether/EtOAc (2:1). green solid (25 mg, 35%). mp: 141−143 °C. 1H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 7.51 (d, J = 7.2 Hz, 1H), 7.33–7.26 (m, 2H), 7.18–7.06 (m, 4H), 6.89 (d, J = 8.0 Hz, 1H), 5.58 (s, 1H), 5.37 (s, 1H), 3.81–3.77 (m, 1H), 2.66 (t, J = 6.8 Hz, 1H), 2.60 (d, J = 6.8 Hz, 1H), 1.82–1.70 (m, 2H), 1.34–1.28 (m, 1H), 1.15 (d, J = 6.4 Hz, 3H), 0.94 (t, J = 7.2 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 181.4, 147.2, 145.1, 141.3, 129.3, 129.0, 127.0, 126.6, 126.3, 122.7, 119.6, 118.6, 109.9, 81.8, 80.6, 69.4, 64.0, 53.6, 51.7, 36.5, 27.2, 17.3, 11.3. HRMS (ESI-TOF): m/z calcd. for C23H25N2O2: 361.1916 [M+H]+; found: 361.1908.

3.2.22. 1′,5a’,6′,11′,11a’,11b’-Hexahydro-3′H-spiro[indoline-3,5′-[6,11]epoxybenzo[f]thiazolo [4,3-a]isoindol]-2-one (5j)

Eluent = petroleum ether/EtOAc (1:1). white solid (57 mg, 78%). mp: 157−159 °C. 1H NMR (500 MHz, CDCl3) δ 9.04 (s, 1H), 7.58 (d, J = 7.5 Hz, 1H), 7.33 (td, J = 7.5, 1.0 Hz, 1H), 7.30 (d, J = 7.0 Hz, 1H), 7.19–7.17 (m, 1H), 7.16–7.11 (m, 3H), 6.97 (dd, J = 8.0, 1.0 Hz, 1H), 5.41 (s, 1H), 4.86 (s, 1H), 4.30 (dt, J = 10.5, 6.5 Hz, 1H), 3.96 (d, J = 8.5 Hz, 1H), 3.39 (d, J = 8.5 Hz, 1H), 3.28 (t, J = 10.0 Hz, 1H), 3.09–3.04 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 181.7, 145.9, 144.8, 141.6, 129.8, 128.6, 127.1, 126.9, 124.8, 122.9, 119.7, 119.3, 110.3, 80.0, 79.6, 72.5, 70.1, 58.2, 50.2, 47.4, 31.8. HRMS (ESI-TOF): m/z calcd. for C22H19N2O2S: 363.1167 [M+H]+; found: 363.1163.

3.2.23. 2′-Cyclohexyl-1′,2′,3′,5a’,6′,11′,11a’,11b’-octahydrospiro[indoline-3,5′-[6,11]epoxybenzo[f]pyrrolo [2,1-a]isoindol]-2-one (5k)

For major isomer: Eluent =petroleum ether/EtOAc (2:1). white solid (39 mg, 46%). mp: 141−143 °C. 1H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 7.56 (d, J = 7.6 Hz, 1H), 7.29 (t, J = 8.0 Hz, 1H), 7.24 (d, J = 7.2 Hz, 1H), 7.15–7.05 (m, 4H), 6.91 (d, J = 8.0 Hz, 1H), 5.42 (s, 1H), 5.15 (s, 1H), 4.13–4.11 (m, 1H), 2.85 (d, J = 7.6 Hz, 1H), 2.79 (t, J = 7.6 Hz, 1H), 2.67 (t, J = 7.6 Hz, 1H), 2.24 (dd, J = 10.0, 6.8 Hz, 1H), 2.14–2.06 (m, 2H), 1.84–1.45 (m, 7H), 1.16–1.07 (m, 3H), 0.96–0.74 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 181.6, 147.3, 145.2, 141.9, 129.1, 128.3, 127.4, 126.8, 126.5, 122.4, 119.6, 118.8, 110.0, 80.6, 80.0, 70.9, 64.8, 57.8, 50.0, 48.5, 46.3, 42.4, 31.8, 31.4, 29.5, 26.7, 26.3, 26.2. HRMS (ESI-TOF): m/z calcd. for C28H31N2O2: 427.2386 [M+H]+; found: 427.2380.
For minor isomer: Eluent =petroleum ether/EtOAc (3:1). white solid (36 mg, 42%). mp: 141−143 °C. 1H NMR (400 MHz, CDCl3) δ 7.93 (s, 1H), 7.55 (d, J = 7.2 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 7.2 Hz, 1H), 7.16–7.04 (m, 4H), 6.91 (d, J = 8.0 Hz, 1H), 5.47 (s, 1H), 5.20 (s, 1H), 4.37–4.31 (m, 1H), 2.81 (d, J = 7.6 Hz, 1H), 2.76 (d, J = 8.8 Hz, 1H), 2.72 (t, J = 8.0 Hz, 1H), 2.56 (t, J = 7.2 Hz, 1H), 2.12–1.98 (m, 2H), 1.83–1.50 (m, 7H), 1.21–1.05 (m, 3H), 0.99–0.82 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 181.9, 146.8, 145.6, 141.9, 129.2, 128.9, 126.9, 126.9, 126.6, 122.1, 119.5, 119.0, 110.1, 80.3, 80.2, 71.0, 65.2, 58.2, 51.6, 49.9, 47.8, 42.1, 32.2, 31.9, 31.0, 26.5, 26.2, 26.1. HRMS (ESI-TOF): m/z calcd. for C28H31N2O2: 427.2386 [M+H]+; found: 427.2382.

3.2.24. 5-Bromo-1′,5a’,6′,11′,11a’,11b’-hexahydro-3′H-spiro[indoline-3,5′-[6,11]epoxybenzo[f]thiazolo [4,3-a]isoindol]-2-one (6)

Eluent = petroleum ether/EtOAc (2:1). white solid (2.14 g, 61%). mp: 280−282 °C. 1H NMR (400 MHz, DMSO-d6) δ 10.63 (s, 1H), 7.49 (dd, J = 8.4, 2.0 Hz, 1H), 7.44 (d, J = 2.0 Hz, 1H), 7.33 (d, J = 7.2 Hz, 1H), 7.25 (d, J = 6.8 Hz, 1H), 7.20–7.08 (m, 2H), 6.87 (d, J = 8.4 Hz, 1H), 5.53 (s, 1H), 4.82 (s, 1H), 4.06–4.00 (m, 1H), 3.71 (d, J = 8.8 Hz, 1H), 3.18 (d, J = 8.4 Hz, 1H), 3.05–2.94 (m, 2H), 2.83 (t, J = 8.0 Hz, 1H), 2.76 (d, J = 8.4 Hz, 1H). 13C NMR (125 MHz, DMSO-d6) δ 179.4, 146.8, 145.5, 143.0, 132.6, 131.0, 127.8, 127.2, 127.0, 120.5, 119.7, 113.8, 112.1, 79.7, 79.4, 71.9, 70.3, 57.9, 50.1, 47.3, 31.7. HRMS (ESI-TOF): m/z calcd. for C21H18BrN2O2S: 441.0272 [M+H]+; found: 441.0268.

3.3. General Procedure for Deoxyaromatization of Cycloaddition Product 6

A mixture of the cycloaddition product 6 (44 mg, 0.1 mmol) and DCM (1 mL) was added to a 25 mL sealed tube at 0 °C. Later, triflic acid (0.1 mL) was added to the system dropwise. Then, the reaction mixture was stirred at room temperature for 3 h. After the reaction was completed, the reaction mixture was diluted with 5.0 mL of DCM and filtered through a plug of Celite, followed by washing with 2 mL of saturated NaHCO3 (aq.). and extracted with DCM three times. The combined organic layers were dried over Na2SO4 and filtered, and the solvent was removed under reduced pressure to give the crude product, which was purified by column chromatography on silica gel.

5′-Bromo-1,11b-dihydro-3H-spiro[benzo[f]thiazolo [4,3-a]isoindole-5,3′-indolin]-2′-one (7)

Eluent = petroleum ether/EtOAc (2:1). white solid (32 mg, 75%). mp: 233−235 °C. 1H NMR (400 MHz, DMSO-d6) δ 10.93 (s, 1H), 8.10 (s, 1H), 8.05 (d, J = 8.0 Hz, 1H), 7.94 (d, J = 8.0 Hz, 1H), 7.63–7.57 (m, 2H), 7.54 (ddd, J = 8.4, 6.8, 1.2 Hz, 1H), 7.44 (s, 1H), 7.14 (d, J = 2.0 Hz, 1H), 7.07 (d, J = 8.4 Hz, 1H), 5.29 (t, J = 7.2 Hz, 1H), 4.28 (d, J = 10.4 Hz, 1H), 3.81 (d, J = 10.4 Hz, 1H), 3.69 (dd, J = 10.4, 7.2 Hz, 1H), 2.88 (dd, J = 10.8, 7.2 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 183.0, 147.2, 145.7, 144.6, 138.5, 138.3, 138.0, 135.5, 134.2, 133.2, 133.1, 131.6, 131.2, 126.5, 126.0, 118.8, 117.4, 81.6, 78.3, 59.3, 44.7. HRMS (ESI-TOF): m/z calcd. for C21H16BrN2OS: 423.0167 [M+H]+; found: 423.0162.

3.4. General Procedure for the Synthesis of N-Boc Substituted Spirooxindole 8

The cycloaddition product 6 (44 mg, 0.1 mmol), DMAP (2.4 mg, 0.02 mmol) and THF were added to a 25 mL sealed tube at 0 °C. Later, the mixture of (Boc)2O (0.12 mmol) and THF (1 mL) was added to the system dropwise. Then, the reaction mixture was stirred at room temperature for 2 h. After the reaction was completed, the reaction mixture was diluted with 10.0 mL of EtOAc and filtered through a plug of Celite, followed by washing with 2 mL of H2O three times, and the organic phase was dried with anhydrous sodium sulfate and filtered, and the solvent was removed under reduced pressure to give the crude product, which was purified by column chromatography on silica gel.

tert-Butyl -5-bromo-2-oxo-1′,5a’,6′,11′,11a’,11b’-hexahydro-3′H-spiro[indoline-3,5′-[6,11]epoxybenzo[f]thiazolo [4,3-a]isoindole]-1-carboxylate (8)

Eluent = petroleum ether/EtOAc (5:1). white solid (51 mg, 93%). mp: 182−184 °C. 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 8.4 Hz, 1H), 7.75 (d, J = 2.4 Hz, 1H), 7.55 (dd, J = 8.4, 2.0 Hz, 1H), 7.29–7.27 (m, 1H), 7.14 -7.09 (m, 3H), 5.44 (s, 1H), 5.01 (s, 1H), 4.31 (dt, J = 10.8, 6.8 Hz, 1H), 3.68 (d, J = 6.8 Hz, 1H), 3.34 (d, J = 6.8 Hz, 1H), 3.13 (t, J = 9.6 Hz, 1H), 2.99–2.95 (m, 2H), 2.83 (t, J = 8.0 Hz, 1H), 1.62 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 176.20, 148.94, 146.14, 144.35, 139.38, 133.02, 130.31, 127.20, 126.96, 126.65, 119.78, 119.18, 118.08, 116.60, 85.09, 79.81, 79.74, 69.76, 68.90, 59.84, 46.95, 45.98, 30.32, 28.06. HRMS (ESI-TOF): m/z calcd. for C26H26BrN2O4S: 541.0797 [M+H]+; found: 541.0796.

3.5. General Procedure for the Reduction of Cycloadduct 6 with Lithium Aluminum Hydride

To a solution of LiAlH4 (43 mg, 1.1 mmol) in anhydrous diethyl ether (2 mL) under an argon atmosphere was added cycloadduct 6 (50 mg, 0.11 mmol), and the reaction mixture was stirred at room temperature for 4 h. After that, the mixture was cooled to 0 °C and 0.5 mL of H2O was added to this mixture. Then, 0.5 mL of a 10% NaOH solution and 0.5 mL of another portion of H2O were added to it. The reaction mixture was stirred for 5 min at ambient temperature. The organic layer was separated, and the aqueous phase was extracted with EtOAc (3 × 5 mL). The total organic mixture was dried over anhydrous Na2SO4 and concentrated under reduced pressure to give the crude product, which was purified by column chromatography on silica gel.

5-Bromo-1′,5a’,6′,11′,11a’,11b’-hexahydro-3′H-spiro[indoline-3,5′-[6,11]epoxybenzo[f]thiazolo [4,3-a]isoindol]-2-ol (9)

Eluent = petroleum ether/EtOAc (3:1). white solid (33 mg, 64%). mp: 147−149 °C.1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 2.0 Hz, 1H), 7.29–7.25 (m, 3H), 7.14–7.07 (m, 4H), 6.60 (d, J = 8.5 Hz, 1H), 5.53 (s, 1H), 5.07 (s, 1H), 3.78 (d, J = 9.0 Hz, 1H), 3.10–3.06 (m, 1H), 2.94 (d, J = 9.0 Hz, 1H), 2.83–2.76 (m, 2H), 2.62 (t, J = 7.0 Hz, 1H), 2.42 (d, J = 7.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 150.7, 146.4, 146.3, 131.9, 129.0, 126.7, 126.6, 119.4, 119.2, 111.6, 110.9, 81.0, 79.5, 77.0, 67.4, 54.3, 51.8, 47.3, 34.5, 24.1. HRMS (ESI-TOF): m/z calcd. for C21H20BrN2O2S: 443.0429 [M+H]+; found: 443.0424.

3.6. Crystallography

Crystal data for 5j C21H18N2O2S, M = 450.54 (5j + solvent: EtOAc), orthorhombic, a = 13.0295(3) Å, b = 9.2645(2) Å, c = 21.1483(4) Å, α = 90°, β = 94.03°, γ = 90°, V = 2546.54(9) Å3, space group P21/n(14), Mu = 1.382 mm−1. Z = 4, T = 267 K, Dx = 1175 g/cm3, which were used in all calculations. The final R1 was 0.0443 (I > 2σ(I)) and wR2 was 0.1398 (all data).
The results of the X-ray diffraction analysis for compound 5j were deposited with the Cambridge Crystallographic Data Centre (CCDC 2243483).

4. Conclusions

Microwave-promoted multicomponent reactions of isatins, α-amino acids and 1,4-dihydro-1,4-epoxynaphthalene have been demonstrated. Under environmentally friendly conditions, a variety of oxygen-bridged spirooxindoles were delivered in good to excellent yields within 15 min. This cascade protocol shows excellent diastereoselectivity and remarkable functional group tolerance, and a diversity of amino acids can be involved in this transformation. This work provides a powerful means to expand the structural diversity of spirooxindole as a promising scaffold for novel drug discovery.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28083508/s1, including 1H, 13C NMR and 19F spectra of [3+2] cycloaddition products 4–6, and 1H and 13C NMR NMR spectra of the derivatizations of the gram reaction product 7–9.

Author Contributions

Conceptualization, H.Z.; methodology, H.Z.; software, Y.S. and H.Z.; validation, H.Z.; formal analysis, Y.S. and H.Z.; investigation, H.Z.; resources, Y.S. and H.Z.; data curation, Y.S. and H.Z.; writing—original draft preparation, H.Z.; writing—review and editing, H.Z.; visualization, Y.S. and H.Z.; supervision, H.Z.; project administration, H.Z.; funding acquisition, H.Z. and Y.Z. All authors have read and agreed to the published version of the manuscript.

Funding

We thank the National Natural Science Foundation of China (no. 22001137), Natural Science Foundation of Zhejiang Province (no. LQ20B020003), and Natural Science Foundation of Ningbo (no. 202003N4111) for financial support.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We sincerely thanks Dongru Sun for her valuable suggestion.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Sample Availability

Samples of the compounds 4–9 are available from the authors.

References

  1. Zuin, V.G.; Eilks, I.; Elschami, M.; Kümmerer, K. Education in green chemistry and in sustainable chemistry: Perspectives towards sustainability. Green Chem. 2021, 23, 1594–1608. [Google Scholar] [CrossRef]
  2. C&EN Global Enterprise. Sustainable chemistry enters new territory. ACS Comment 2022, 100, 27. [Google Scholar]
  3. Kar, S.; Sanderson, H.; Roy, K.; Benfenati, E.; Leszczynski, J. Green chemistry in the synthesis of pharmaceuticals. Chem. Rev. 2022, 122, 3637–3710. [Google Scholar] [CrossRef]
  4. Lew, A.; Krutzik, P.O.; Hart, M.E.; Chamberlin, A.R. Increasing rates of reaction:  Microwave-assisted organic synthesis for combinatorial chemistry. J. Comb. Chem. 2002, 4, 95–105. [Google Scholar] [CrossRef]
  5. Singh, B.K.; Kaval, N.; Tomar, S.; Eycken, E.V.D.; Parmar, V.S. Transition metal-catalyzed carbon−carbon bond formation suzuki, heck, and sonogashira reactions using microwave and microtechnology. Org. Process Res. Dev. 2008, 12, 468–474. [Google Scholar] [CrossRef]
  6. Kruithof, A.; Ruijter, E.; VA Orru, R. Microwave-assisted multicomponent synthesis of heterocycles. Curr. Org. Chem. 2011, 15, 204–236. [Google Scholar] [CrossRef]
  7. Beillard, A.; Bantreil, X.; Métro, T.-X.; Martinez, J.; Lamaty, F. Alternative technologies that facilitate access to discrete metal complexes. Chem. Rev. 2019, 119, 7529–7609. [Google Scholar] [CrossRef]
  8. Fairoosa, J.; Saranya, S.; Radhika, S.; Anilkumar, G. Recent advances in microwave assisted multicomponent reactions. Chemistryselect 2020, 5, 5180–5197. [Google Scholar] [CrossRef]
  9. Ganem, B. Strategies for innovation in multicomponent reaction design. Acc. Chem. Res. 2009, 42, 463–472. [Google Scholar] [CrossRef]
  10. Touré, B.B.; Hall, D.G. Natural product synthesis using multicomponent reaction strategies. Chem. Rev. 2009, 109, 4439–4486. [Google Scholar] [CrossRef] [PubMed]
  11. Ruijter, E.; Scheffelaar, R.; Orru, R.V.A. Multicomponent reaction design in the quest for molecular complexity and diversity. Angew. Chem. Int. Ed. 2011, 50, 6234–6246. [Google Scholar] [CrossRef]
  12. Rotstein, B.H.; Zaretsky, S.; Rai, V.; Yudin, A.K. Small heterocycles in multicomponent reactions. Chem. Rev. 2014, 114, 8323–8359. [Google Scholar] [CrossRef] [PubMed]
  13. Radtke, L.; Marqués-López, E.; Herrera, R.P. Multicomponent Reactions: Concepts and Applications for Design and Synthesis; John Wiley & Sons: Hoboken, NJ, USA, 2015; Volume 6, pp. 198–246. [Google Scholar]
  14. Yu, B.; Yu, D.-Q.; Liu, H.-M. Spirooxindoles: Promising scaffolds for anticancer agents. Eur. J. Med. Chem. 2015, 97, 673–698. [Google Scholar] [CrossRef] [PubMed]
  15. Ye, N.; Chen, H.; Wold, E.A.; Shi, P.-Y.; Zhou, J. Therapeutic potential of spirooxindoles as antiviral agents. ACS Infect. Dis. 2016, 2, 382–392. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, Y.; Panek, J.S. Stereocontrolled synthesis of spirooxindoles through lewis acid-promoted [5 + 2]-annulation of chiral silyl alcohols. Org. Lett. 2009, 11, 3366–3369. [Google Scholar] [CrossRef]
  17. White, J.D.; Li, Y.; Ihle, D.C. Tandem intramolecular photocycloaddition−retro-mannich fragmentation as a route to spiro[pyrrolidine-3,3′-oxindoles]. Total synthesis of (±)-coerulescine, (±)-horsfiline, (±)-elacomine, and (±)-6-deoxyelacomine. J. Org. Chem. 2010, 75, 3569–3577. [Google Scholar] [CrossRef]
  18. Jiang, D.; Dong, S.; Tang, W.; Lu, T.; Du, D. N-heterocyclic carbene-catalyzed formal [3 + 2] annulation of α-bromoenals with 3-aminooxindoles: A stereoselective synthesis of spirooxindole γ-butyrolactams. J. Org. Chem. 2015, 80, 11593–11597. [Google Scholar] [CrossRef] [PubMed]
  19. Huang, X.; Liu, M.; Pham, K.; Zhang, X.; Yi, W.-B.; Jasinski, J.P.; Zhang, W. Organocatalytic one-pot asymmetric synthesis of thiolated spiro-γ-lactam oxindoles bearing three stereocenters. J. Org. Chem. 2016, 81, 5362–5369. [Google Scholar] [CrossRef]
  20. Yang, P.; Wang, X.; Chen, F.; Zhang, Z.-B.; Chen, C.; Peng, L.; Wang, L.-X. Organocatalytic enantioselective michael/cyclization domino reaction between 3-amideoxindoles and α, β-unsaturated aldehydes: One-pot preparation of chiral spirocyclic oxindole-γ-lactams. J. Org. Chem. 2017, 82, 3908–3916. [Google Scholar] [CrossRef] [PubMed]
  21. Kong, L.; Sun, Y.; Zheng, Z.; Tang, R.; Wang, M.; Li, Y. Chemoselective N–H or C-2 arylation of indole-2-carboxamides: Controllable synthesis of indolo[1,2-a]quinoxalin-6-ones and 2,3′-spirobi[indolin]-2′-ones. Org. Lett. 2018, 20, 5251–5255. [Google Scholar] [CrossRef]
  22. Ni, Q.; Wang, X.; Zeng, D.; Wu, Q.; Song, X. Organocatalytic asymmetric synthesis of aza-spirooxindoles via michael/friedel–crafts cascade reaction of 1,3-nitroenynes and 3-pyrrolyloxindoles. Org. Lett. 2021, 23, 2273–2278. [Google Scholar] [CrossRef]
  23. Saleh, S.A.; Hazra, A.; Singh, M.S.; Hajra, S. Selective C3-allylation and formal [3 + 2]-annulation of spiro-aziridine oxindoles: Synthesis of 5′-substituted spiro[pyrrolidine-3,3′-oxindoles] and coerulescine. J. Org. Chem. 2022, 87, 8656–8671. [Google Scholar] [CrossRef]
  24. Wang, D.; Zhang, W.; Lu, X.; Zhou, H.; Zhong, F. Cinchona alkaloid derived iodide catalyzed enantioselective oxidative α-amination of carbonyl compounds toward the construction of spiroindolyloxindole. Org. Lett. 2022, 24, 842–847. [Google Scholar] [CrossRef] [PubMed]
  25. Efremov, I.V.; Vajdos, F.F.; Borzilleri, K.A.; Capetta, S.; Chen, H.; Dorff, P.H.; Dutra, J.K.; Goldstein, S.W.; Mansour, M.; McColl, A.; et al. Discovery and optimization of a novel spiropyrrolidine inhibitor of β-secretase (BACE1) through fragment-based drug design. J. Med. Chem. 2012, 55, 9069–9088. [Google Scholar] [CrossRef] [PubMed]
  26. Shanmugam, P.; Viswambharan, B.; Madhavan, S. Synthesis of novel functionalized 3-spiropyrrolizidine and 3-spiropyrrolidine oxindoles from baylis−hillman adducts of isatin and heteroaldehydes with azomethine ylides via [3 + 2]-cycloaddition. Org. Lett. 2007, 9, 4095–4098. [Google Scholar] [CrossRef]
  27. Filatov, A.S.; Knyazev, N.A.; Molchanov, A.P.; Panikorovsky, T.L.; Kostikov, R.R.; Larina, A.G.; Boitsov, V.M.; Stepakov, A.V. Synthesis of functionalized 3-spiro[cyclopropa[a]pyrrolizine]- and 3-spiro[3-azabicyclo[3.1.0]hexane]oxindoles from cyclopropenes and azomethine ylides via [3 + 2]-cycloaddition. J. Org. Chem. 2017, 82, 959–975. [Google Scholar] [CrossRef] [PubMed]
  28. Wang, X.; Yang, P.; Zhang, Y.; Tang, C.-Z.; Tian, F.; Peng, L.; Wang, L.-X. Isatin N, N′-cyclic azomethine imine 1,3-dipole and abnormal [3 + 2]-cycloaddition with maleimide in the presence of 1,4-diazabicyclo[2.2.2]octane. Org. Lett. 2017, 19, 646–649. [Google Scholar] [CrossRef] [PubMed]
  29. Bhandari, S.; Sana, S.; Sridhar, B.; Shankaraiah, N. Microwave-assisted one-pot [3+2] cycloaddition of azomethine ylides and 3-alkenyl oxindoles: A facile approach to pyrrolidine-fused bis-spirooxindoles. Chemistryselect 2019, 4, 1727–1730. [Google Scholar] [CrossRef]
  30. Gugkaeva, Z.T.; Panova, M.V.; Smol’yakov, A.F.; Medvedev, M.G.; Tsaloev, A.T.; Godovikov, I.A.; Maleev, V.I.; Larionov, V.A. Asymmetric metal-templated route to amino acids with 3-spiropyrrolidine oxindole core via a 1,3-dipolar addition of azomethine ylides to a chiral dehydroalanine Ni(II) complex. Adv. Synth. Catal. 2022, 364, 2395–2402. [Google Scholar] [CrossRef]
  31. Wang, K.-K.; Li, Y.-L.; Chen, R.-X.; Sun, A.-L.; Wang, Z.-Y.; Zhao, Y.-C.; Wang, M.-Y.; Sheng, S. Substrate-controlled regioselectivity switch in a three-component 1,3-dipolar cycloaddition reaction to access 3,3′-pyrrolidinyl-spirooxindoles derivatives. Adv. Synth. Catal. 2022, 364, 2047–2052. [Google Scholar] [CrossRef]
  32. Nishimura, T.; Kawamoto, T.; Sasaki, K.; Tsurumaki, E.; Hayashi, T. Rhodium-catalyzed asymmetric cyclodimerization of oxa- and azabicyclic alkenes. J. Am. Chem. Soc. 2007, 129, 1492–1493. [Google Scholar] [CrossRef] [PubMed]
  33. Chen, S.; Yao, Y.; Yang, W.; Lin, Q.; Wang, L.; Li, H.; Chen, D.; Tan, Y.; Yang, D. Three-component cycloaddition to synthesize aziridines and 1,2,3-triazolines. J. Org. Chem. 2019, 84, 11863–11872. [Google Scholar] [CrossRef] [PubMed]
  34. Yao, Y.; Yang, W.; Lin, Q.; Yang, W.; Li, H.; Wang, L.; Gu, F.; Yang, D. 1,3-Dipolar cycloaddition of nitrones to oxa(aza)bicyclic alkenes. Org. Chem. Front. 2019, 6, 3360–3364. [Google Scholar] [CrossRef]
  35. Lin, Q.; Yang, W.; Yao, Y.; Li, Y.; Wang, L.; Yang, D. Copper-catalyzed cycloaddition of heterobicyclic alkenes with diaryl disulfides to synthesize dihydrobenzo[b]thiophene derivatives. J. Org. Chem. 2021, 86, 4193–4204. [Google Scholar] [CrossRef] [PubMed]
  36. Chen, W.; Yang, W.; Wu, R.; Yang, D. Water-promoted synthesis of fused bicyclic triazolines and naphthols from oxa(aza)bicyclic alkenes and transformation via a novel ring-opening/rearrangement reaction. Green Chem. 2018, 20, 2512–2518. [Google Scholar] [CrossRef]
  37. Yuan, K.; Zhang, T.K.; Hou, X.L. A highly efficient palladacycle catalyst for hydrophenylation of C-, N-, and O--substituted bicyclic alkenes under aerobic condition. J. Org. Chem. 2005, 70, 6085–6088. [Google Scholar] [CrossRef]
  38. Li, S.; Lu, Z.; Meng, L.; Wang, J. Iridium-catalyzed asymmetric addition of thiophenols to oxabenzonorbornadienes. Org. Lett. 2016, 18, 5276–5279. [Google Scholar] [CrossRef]
  39. Yao, Y.; Yang, W.; Wang, C.; Gu, F.; Yang, W.; Yang, D. Radical addition of thiols to oxa(aza)bicyclic alkenes in water. Asian J. Org. Chem. 2019, 8, 506–513. [Google Scholar] [CrossRef]
  40. Kim, K.; Lee, Y. Copper-catalyzed hydroamination of oxa- and azabenzonorbornadienes with pyrazoles. J. Org. Chem. 2022, 87, 569–578. [Google Scholar] [CrossRef]
  41. Zhang, K.; Khan, R.; Chen, J.; Zhang, X.; Gao, Y.; Zhou, Y.; Li, K.; Tian, Y.; Fan, B. Directing-group-controlled ring-opening addition and hydroarylation of oxa/azabenzonorbornadienes with arenes via C-H activation. Org. Lett. 2020, 22, 3339–3344. [Google Scholar] [CrossRef] [PubMed]
  42. Li, X.; Pan, X.; Qi, Z.; Li, X. Palladium-catalyzed [3 + 2] annulation of aryl halides with 7-oxa- and 7-azabenzonorbornadienes via C(sp2 or sp3)–H activation. Org. Lett. 2022, 24, 8964–8968. [Google Scholar] [CrossRef] [PubMed]
  43. Kumaran, S.; Saritha, R.; Gurumurthy, P.; Parthasarathy, K. Synthesis of fused spiropyrrolidine oxindoles through 1,3-dipolar cycloaddition of azomethine ylides prepared from isatins and α-amino acids with heterobicyclic alkenes. Eur. J. Org. Chem. 2020, 2020, 2725–2729. [Google Scholar] [CrossRef]
  44. Shen, P.; Guo, Y.; Wei, J.; Zhao, H.; Zhai, H.; Zhao, Y. Straightforward synthesis of succinimide-fused pyrrolizidines by a three-component reaction of α-diketone, amino acid, and maleimide. Synthesis 2020, 53, 1262–1270. [Google Scholar]
  45. Haddad, S.; Boudriga, S.; Porzio, F.; Soldera, A.; Askri, M.; Knorr, M.; Rousselin, Y.; Kubicki, M.M.; Golz, C.; Strohmann, C. Regio- and stereoselective synthesis of spiropyrrolizidines and piperazines through azomethine ylide cycloaddition reaction. J. Org. Chem. 2015, 80, 9064–9075. [Google Scholar] [CrossRef]
Molecules 28 03508 sch001 550
Scheme 1. (a) Previous work of 1,3-dipolar cycloaddition of isatins, α-amino acids and oxabicyclic alkenes, (b) Our previous work of 1,3-dipolar cycloaddition, and (c) Microwave-promoted multicomponent reaction with diverse primary amino acids as reaction partner (This Work).
Scheme 1. (a) Previous work of 1,3-dipolar cycloaddition of isatins, α-amino acids and oxabicyclic alkenes, (b) Our previous work of 1,3-dipolar cycloaddition, and (c) Microwave-promoted multicomponent reaction with diverse primary amino acids as reaction partner (This Work).
Molecules 28 03508 sch001
Molecules 28 03508 sch002 550
Scheme 2. Reaction scope with respect to isatins and α-dicarbonyl compounds. Reagents and conditions: 1 (0.2 mmol), 2a (0.2 mmol), 3a (0.3 mmol), MeOH (2 mL), 70 °C, 15 min under air in a microwave reactor.
Scheme 2. Reaction scope with respect to isatins and α-dicarbonyl compounds. Reagents and conditions: 1 (0.2 mmol), 2a (0.2 mmol), 3a (0.3 mmol), MeOH (2 mL), 70 °C, 15 min under air in a microwave reactor.
Molecules 28 03508 sch002
Molecules 28 03508 sch003 550
Scheme 3. Reaction scope with respect to amino acids a. a Reagents and conditions: 1a (0.20 mmol), 2 (0.2 mmol), 3a (0.3 mmol), MeOH/H2O = 3:1 (2 mL), 70 °C, 15 min under air in a microwave reactor. b MeOH (2 mL) was used as solvent.
Scheme 3. Reaction scope with respect to amino acids a. a Reagents and conditions: 1a (0.20 mmol), 2 (0.2 mmol), 3a (0.3 mmol), MeOH/H2O = 3:1 (2 mL), 70 °C, 15 min under air in a microwave reactor. b MeOH (2 mL) was used as solvent.
Molecules 28 03508 sch003
Molecules 28 03508 sch004 550
Scheme 4. Proposed reaction mechanisms.
Scheme 4. Proposed reaction mechanisms.
Molecules 28 03508 sch004
Molecules 28 03508 sch005 550
Scheme 5. Gram scale experiment and derivatization of compound 6.
Scheme 5. Gram scale experiment and derivatization of compound 6.
Molecules 28 03508 sch005
Table
Table 1. Optimization of reaction conditions a.
Table 1. Optimization of reaction conditions a.
Molecules 28 03508 i001
EntrySolventTep.(°C)TimeYield(100%) b
1THF7015 min40
2DMF7015 min33
3DMSO7015 min46
4Toluene7015 min8
5MeOH7015 min73
6EtOH7015 min60
7iPrOH7015 min70
8tBuOH7015 min48
9MeOH6015 min61
10MeOH8015 min60
11MeOH9015 min64
12MeOH7020 min69
13MeOH7025 min73
14MeOH7030 min72
15MeOH7010 min61
16 cMeOH7015 min81
17 dMeOH7015 min83
a Reaction conditions: 1a (0.1 mmol), 2a (0.1 mmol), and 3a (0.1 mmol) were sealed in a glass vial without degassing of air and placed in a microwave reactor. b Isolated yields. c 1a:2a:3a = 1:1:1.2. d 1a:2a:3a = 1:1:1.5.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shi, Y.; Zhao, H.; Zhao, Y. An Efficient Synthesis of Oxygen-Bridged Spirooxindoles via Microwave-Promoted Multicomponent Reaction. Molecules 2023, 28, 3508. https://doi.org/10.3390/molecules28083508

AMA Style

Shi Y, Zhao H, Zhao Y. An Efficient Synthesis of Oxygen-Bridged Spirooxindoles via Microwave-Promoted Multicomponent Reaction. Molecules. 2023; 28(8):3508. https://doi.org/10.3390/molecules28083508

Chicago/Turabian Style

Shi, Yaojing, Hua Zhao, and Yufen Zhao. 2023. "An Efficient Synthesis of Oxygen-Bridged Spirooxindoles via Microwave-Promoted Multicomponent Reaction" Molecules 28, no. 8: 3508. https://doi.org/10.3390/molecules28083508

APA Style

Shi, Y., Zhao, H., & Zhao, Y. (2023). An Efficient Synthesis of Oxygen-Bridged Spirooxindoles via Microwave-Promoted Multicomponent Reaction. Molecules, 28(8), 3508. https://doi.org/10.3390/molecules28083508

Article Metrics

Back to TopTop